Medical Countermeasures U.S. Replenishes Smallpox and Mpox Vaccine Stockpile in $52.7 Million Contract AwardGlobal Biodefense StaffJune 29, 2026
Medical Countermeasures WHO Launches Clinical Trial of Two Experimental Ebola Treatments in DRCGlobal Biodefense StaffJune 25, 2026
Medical Countermeasures Experimental Two-in-One Vaccine Shows Early Promise Against Lassa Fever and RabiesGlobal Biodefense StaffJune 19, 2026
BARDA Seeks Input from Suppliers on Potential SARS-CoV-2 Medical Countermeasures Contracts + Grants February 2, 2020 …
CureVac and CEPI Extend Their Cooperation to Develop a Vaccine Against COVID-19 Medical Countermeasures January 31, 2020 …
NanoViricides Confirms It Has Been Working On Treatment for Novel Coronavirus Medical Countermeasures January 30, 2020 …
Inovio, Beijing Advaccine Collaborate to Advance INO-4800 Vaccine Medical Countermeasures January 30, 2020 …
AbCellera is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of its DARPA P3 Program Medical Countermeasures January 29, 2020 …
Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV Medical Countermeasures January 24, 2020 …
CEPI to Fund Development of Multiple Candidate Vaccines Against the Novel Coronavirus Medical Countermeasures January 23, 2020 …
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus Medical Countermeasures January 23, 2020 …
Revocation of Emergency Use Authorizations of Zika, Ebola Diagnostics Medical Countermeasures January 12, 2020 …
Emory University to Lead Infectious Diseases Clinical Research Consortium Leadership Group Medical Countermeasures January 3, 2020 …
Investigational Drugs Reduce Risk of Death from Ebola Virus Disease Medical Countermeasures December 2, 2019 …
Phase 3 Trial of Modified Vaccinia Ankara as a Smallpox Vaccine Medical Countermeasures November 14, 2019 …
Carb-X Funds Techulon’s Rapidly Adaptable Nano Therapeutic in Fight Against Drug Resistant Bacteria Antimicrobial Resistance November 11, 2019 …
Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral Industry News November 8, 2019 …
Highly Diluted Dose of Ebola Vaccine Shown Effective in Primate Study Medical Countermeasures October 20, 2019 …
